• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症中神经肌肉功能障碍的定量评估。

Quantitative assessment of neuromuscular deficit in ALS.

作者信息

Andres P L, Thibodeau L M, Finison L J, Munsat T L

出版信息

Neurol Clin. 1987 Feb;5(1):125-41.

PMID:3550414
Abstract

Several criteria must be met in developing a test battery forr ALS. First, the test items should be designed to answer the specific questions being asked. If questions involve the amount and rate of deterioration, then the test items should generate interval data and show evidence that they reflect change in the disease itself. Second, the reliability of the test items should be carefully determined. Are the variances due to testing errors such as inconsistent positioning or changes in verbal instructions; or do they reflect human performance variation? Third, the test items must be sensitive to small changes, and one must be able to test the very strong as well as the severely debilitated patient. The TQNE was designed to measure degree of disease progression in ALS. The major portion of the protocol consists of isometric force measurement using an electronic strain gauge. Other quantitative segments include tests of pulmonary function, speech rates, and timed activities. Using z-score transformations, we have summarized these test items into five megascores: pulmonary function, bulbar function, timed hand activities, arm strength, and leg strength. Megascores have been used to characterize the natural history of the disease and to judge therapeutic efficacy. Quantitative methods to measure deficit in neuromuscular disease lag far behind other technologic advances in medical research. Future advances in the measurement of neuromuscular deficit depend on the commitment of researchers to invest the time and resources necessary to develop more sensitive and reliable testing techniques.

摘要

在开发用于肌萎缩侧索硬化症(ALS)的测试组合时必须满足几个标准。首先,测试项目的设计应能回答所提出的具体问题。如果问题涉及恶化的程度和速度,那么测试项目应生成区间数据,并显示出它们反映疾病本身变化的证据。其次,应仔细确定测试项目的可靠性。这些差异是由于测试误差,如定位不一致或口头指示的变化;还是它们反映了人类表现的差异?第三,测试项目必须对微小变化敏感,并且必须能够对病情非常严重以及极度衰弱的患者进行测试。TQNE旨在测量ALS疾病进展的程度。该方案的主要部分包括使用电子应变仪进行等长肌力测量。其他定量部分包括肺功能测试、言语速度测试和定时活动测试。通过z分数转换,我们将这些测试项目总结为五个综合得分:肺功能、延髓功能、定时手部活动、手臂力量和腿部力量。综合得分已被用于描述疾病的自然史和判断治疗效果。测量神经肌肉疾病缺陷的定量方法远远落后于医学研究中的其他技术进步。神经肌肉缺陷测量的未来进展取决于研究人员投入时间和资源开发更敏感、更可靠测试技术的决心。

相似文献

1
Quantitative assessment of neuromuscular deficit in ALS.肌萎缩侧索硬化症中神经肌肉功能障碍的定量评估。
Neurol Clin. 1987 Feb;5(1):125-41.
2
Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis.使用综合评分(总分)来衡量肌萎缩侧索硬化症的缺陷。
Neurology. 1988 Mar;38(3):405-8. doi: 10.1212/wnl.38.3.405.
3
The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.肌萎缩侧索硬化功能评定量表。肌萎缩侧索硬化患者日常生活活动能力评估。肌萎缩侧索硬化睫状神经营养因子治疗研究(ACTS)I-II期研究组。
Arch Neurol. 1996 Feb;53(2):141-7.
4
Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials.在肌萎缩侧索硬化症治疗试验中使用电生理测试来测量疾病进展。
Muscle Nerve. 1990 Jun;13(6):471-9. doi: 10.1002/mus.880130602.
5
[Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].肌萎缩侧索硬化功能评定量表的研究:修订版肌萎缩侧索硬化功能评定量表(ALSFRS-R)日语版
No To Shinkei. 2001 Apr;53(4):346-55.
6
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).利鲁唑用于治疗肌萎缩侧索硬化症(ALS)/运动神经元病(MND)。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206.
7
Quantitative motor assessment in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的定量运动评估
Neurology. 1986 Jul;36(7):937-41. doi: 10.1212/wnl.36.7.937.
8
Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.肌萎缩侧索硬化症病情进展的临床及神经生理学评估
Muscle Nerve. 2003 Nov;28(5):630-3. doi: 10.1002/mus.10469.
9
Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.儿童复发性腹痛多维测量方法的开发:在三种环境下开展的基于人群的研究
Pediatrics. 2005 Feb;115(2):e210-5. doi: 10.1542/peds.2004-1412.
10
Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales.肌萎缩侧索硬化症的自然病史。使用查令十字肌萎缩侧索硬化症评定量表的观察结果。
Adv Neurol. 1995;68:185-98.

引用本文的文献

1
Genetic and Mechanistic Insights Inform Amyotrophic Lateral Sclerosis Treatment and Symptomatic Management: Current and Emerging Therapeutics and Clinical Trial Design Considerations.基因与机制见解为肌萎缩侧索硬化症的治疗及症状管理提供依据:当前与新兴疗法及临床试验设计考量
CNS Drugs. 2025 Sep 2. doi: 10.1007/s40263-025-01217-0.
2
Measuring disease progression in primary lateral sclerosis.原发性侧索硬化症的疾病进展测量。
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(sup1):59-66. doi: 10.1080/21678421.2020.1837179.
3
Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS).
肌萎缩侧索硬化症(ALS)的临床谱
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):a024117. doi: 10.1101/cshperspect.a024117.
4
Strength Testing in Motor Neuron Diseases.运动神经元疾病的力量测试
Neurotherapeutics. 2017 Jan;14(1):154-160. doi: 10.1007/s13311-016-0472-0.
5
Quantitative strength testing in ALS clinical trials.肌萎缩侧索硬化症临床试验中的定量力量测试。
Neurology. 2016 Aug 9;87(6):617-24. doi: 10.1212/WNL.0000000000002941. Epub 2016 Jul 6.
6
Resistance strength training exercise in children with spinal muscular atrophy.脊髓性肌萎缩症患儿的抗阻力量训练运动
Muscle Nerve. 2015 Oct;52(4):559-67. doi: 10.1002/mus.24568.
7
Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中舌肌组织评估的电阻抗肌电图
Muscle Nerve. 2015 Oct;52(4):584-91. doi: 10.1002/mus.24565. Epub 2015 Jun 3.
8
Measures and markers in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的测量方法和标志物
NeuroRx. 2004 Apr;1(2):273-83. doi: 10.1602/neurorx.1.2.273.
9
CT muscle scanning in the evaluation of patients with spinal muscular atrophy (SMA).CT肌肉扫描在脊髓性肌萎缩症(SMA)患者评估中的应用
Neuroradiology. 1988;30(6):487-95. doi: 10.1007/BF00339688.